BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 28765537)

  • 1. PRDX2 in Myocyte Hypertrophy and Survival is Mediated by TLR4 in Acute Infarcted Myocardium.
    Jin X; Chen C; Li D; Su Q; Hang Y; Zhang P; Hu W
    Sci Rep; 2017 Aug; 7(1):6970. PubMed ID: 28765537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxiredoxin2 (Prdx2) Reduces Oxidative Stress and Apoptosis of Myocardial Cells Induced by Acute Myocardial Infarction by Inhibiting the TLR4/Nuclear Factor kappa B (NF-κB) Signaling Pathway.
    Li H; Yang H; Wang D; Zhang L; Ma T
    Med Sci Monit; 2020 Dec; 26():e926281. PubMed ID: 33268762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deregulation of XBP1 expression contributes to myocardial vascular endothelial growth factor-A expression and angiogenesis during cardiac hypertrophy in vivo.
    Duan Q; Ni L; Wang P; Chen C; Yang L; Ma B; Gong W; Cai Z; Zou MH; Wang DW
    Aging Cell; 2016 Aug; 15(4):625-33. PubMed ID: 27133203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxiredoxin 2 is upregulated in colorectal cancer and contributes to colorectal cancer cells' survival by protecting cells from oxidative stress.
    Lu W; Fu Z; Wang H; Feng J; Wei J; Guo J
    Mol Cell Biochem; 2014 Feb; 387(1-2):261-70. PubMed ID: 24234423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in NO/ROS ratio and expression of Trx1 and Prdx2 in isoproterenol-induced cardiac hypertrophy.
    Su H; Pistolozzi M; Shi X; Sun X; Tan W
    Acta Biochim Biophys Sin (Shanghai); 2017 Nov; 49(11):1022-1028. PubMed ID: 29036266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STVNa Attenuates Isoproterenol-Induced Cardiac Hypertrophy Response through the HDAC4 and Prdx2/ROS/Trx1 Pathways.
    Liu F; Su H; Liu B; Mei Y; Ke Q; Sun X; Tan W
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31968660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HOTAIR promotes inflammatory response after acute myocardium infarction by upregulating RAGE.
    Lu W; Zhu L; Ruan ZB; Wang MX; Ren Y; Li W
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7423-7430. PubMed ID: 30468490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of peroxiredoxin 2 inhibits TGF-β1-induced epithelial-mesenchymal transition and cell migration in colorectal cancer.
    Feng J; Fu Z; Guo J; Lu W; Wen K; Chen W; Wang H; Wei J; Zhang S
    Mol Med Rep; 2014 Aug; 10(2):867-73. PubMed ID: 24920174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An injectable silk sericin hydrogel promotes cardiac functional recovery after ischemic myocardial infarction.
    Song Y; Zhang C; Zhang J; Sun N; Huang K; Li H; Wang Z; Huang K; Wang L
    Acta Biomater; 2016 Sep; 41():210-23. PubMed ID: 27262742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxiredoxin 2 is involved in vasculogenic mimicry formation by targeting VEGFR2 activation in colorectal cancer.
    Zhang S; Fu Z; Wei J; Guo J; Liu M; Du K
    Med Oncol; 2015 Jan; 32(1):414. PubMed ID: 25471788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxiredoxin 2 inhibits granulosa cell apoptosis during follicle atresia through the NFKB pathway in mice.
    Yang S; Luo A; Hao X; Lai Z; Ding T; Ma X; Mayinuer M; Shen W; Wang X; Lu Y; Ma D; Wang S
    Biol Reprod; 2011 Jun; 84(6):1182-9. PubMed ID: 21248284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated toll-like receptor 4 in monocytes is associated with heart failure after acute myocardial infarction.
    Satoh M; Shimoda Y; Maesawa C; Akatsu T; Ishikawa Y; Minami Y; Hiramori K; Nakamura M
    Int J Cardiol; 2006 May; 109(2):226-34. PubMed ID: 16051384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prdx2 Upregulation Promotes the Growth and Survival of Gastric Cancer Cells.
    Zhang S; He J; Tang M; Sun H
    Pathol Oncol Res; 2020 Jul; 26(3):1869-1877. PubMed ID: 31807984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linkage of inflammation and oxidative stress via release of glutathionylated peroxiredoxin-2, which acts as a danger signal.
    Salzano S; Checconi P; Hanschmann EM; Lillig CH; Bowler LD; Chan P; Vaudry D; Mengozzi M; Coppo L; Sacre S; Atkuri KR; Sahaf B; Herzenberg LA; Herzenberg LA; Mullen L; Ghezzi P
    Proc Natl Acad Sci U S A; 2014 Aug; 111(33):12157-62. PubMed ID: 25097261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of S100A1 in hypoxia-induced inflammatory response in cardiomyocytes via TLR4/ROS/NF-κB pathway.
    Yu J; Lu Y; Li Y; Xiao L; Xing Y; Li Y; Wu L
    J Pharm Pharmacol; 2015 Sep; 67(9):1240-50. PubMed ID: 25880347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of peroxiredoxin2 downregulation in recurrent miscarriage through regulation of trophoblast proliferation and apoptosis.
    Wu F; Tian F; Zeng W; Liu X; Fan J; Lin Y; Zhang Y
    Cell Death Dis; 2017 Jun; 8(6):e2908. PubMed ID: 28661480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxiredoxin 2 is associated with colorectal cancer progression and poor survival of patients.
    Peng L; Wang R; Shang J; Xiong Y; Fu Z
    Oncotarget; 2017 Feb; 8(9):15057-15070. PubMed ID: 28125800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxiredoxin 2 knockdown by RNA interference inhibits the growth of colorectal cancer cells by downregulating Wnt/β-catenin signaling.
    Lu W; Fu Z; Wang H; Feng J; Wei J; Guo J
    Cancer Lett; 2014 Feb; 343(2):190-9. PubMed ID: 24125860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Huoxue Anxin Recipe () promotes myocardium angiogenesis of acute myocardial infarction rats by up-regulating miR-210 and vascular endothelial growth factor.
    Wang J; Zhang Y; Liu YM; Guo LL; Wu P; Dong Y; Wu GJ
    Chin J Integr Med; 2016 Sep; 22(9):685-90. PubMed ID: 27392480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxiredoxin 2 specifically regulates the oxidative and metabolic stress response of human metastatic breast cancer cells in lungs.
    Stresing V; Baltziskueta E; Rubio N; Blanco J; Arriba MC; Valls J; Janier M; Clézardin P; Sanz-Pamplona R; Nieva C; Marro M; Petrov D; Sierra A
    Oncogene; 2013 Feb; 32(6):724-35. PubMed ID: 22430214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.